Perrigo Company plc (NYSE:PRGO) Shares Sold by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC trimmed its position in Perrigo Company plc (NYSE:PRGO) by 8.5% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 3,150,321 shares of the company’s stock after selling 294,408 shares during the quarter. Perrigo comprises about 1.3% of Thompson Siegel & Walmsley LLC’s portfolio, making the stock its 16th biggest holding. Thompson Siegel & Walmsley LLC’s holdings in Perrigo were worth $80,900,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Central Pacific Bank Trust Division acquired a new stake in shares of Perrigo in the first quarter worth approximately $48,000. Parallel Advisors LLC boosted its stake in Perrigo by 69.1% during the 4th quarter. Parallel Advisors LLC now owns 2,009 shares of the company’s stock worth $65,000 after purchasing an additional 821 shares during the last quarter. Beach Investment Counsel Inc. PA purchased a new stake in shares of Perrigo during the second quarter worth $72,000. TFC Financial Management Inc. raised its position in shares of Perrigo by 39.7% in the first quarter. TFC Financial Management Inc. now owns 2,462 shares of the company’s stock valued at $79,000 after buying an additional 700 shares during the last quarter. Finally, Voisard Asset Management Group Inc. boosted its position in Perrigo by 520.0% during the second quarter. Voisard Asset Management Group Inc. now owns 4,650 shares of the company’s stock worth $119,000 after acquiring an additional 3,900 shares during the last quarter. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Perrigo Price Performance

Shares of PRGO stock opened at $27.75 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.99 and a quick ratio of 1.24. The company has a market capitalization of $3.78 billion, a PE ratio of -396.43 and a beta of 0.49. The firm’s 50-day moving average is $27.83 and its two-hundred day moving average is $28.75. Perrigo Company plc has a 12 month low of $24.82 and a 12 month high of $34.60.

Perrigo (NYSE:PRGO) last released its quarterly earnings results on Friday, August 2nd. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.46 by $0.07. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.13 billion. Perrigo had a negative net margin of 2.81% and a positive return on equity of 6.79%. The business’s revenue for the quarter was down 10.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.63 EPS. Analysts predict that Perrigo Company plc will post 2.57 earnings per share for the current year.

Perrigo Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 17th. Stockholders of record on Friday, August 30th will be issued a dividend of $0.276 per share. This represents a $1.10 dividend on an annualized basis and a dividend yield of 3.98%. The ex-dividend date is Friday, August 30th. Perrigo’s dividend payout ratio is presently -1,571.43%.

Insider Buying and Selling

In other Perrigo news, Director Katherine C. Doyle sold 8,954 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $27.30, for a total transaction of $244,444.20. Following the completion of the transaction, the director now owns 6,009 shares of the company’s stock, valued at $164,045.70. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, EVP Svend Andersen sold 28,300 shares of the stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $27.75, for a total transaction of $785,325.00. Following the transaction, the executive vice president now owns 73,553 shares of the company’s stock, valued at approximately $2,041,095.75. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Katherine C. Doyle sold 8,954 shares of Perrigo stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $27.30, for a total value of $244,444.20. Following the completion of the transaction, the director now directly owns 6,009 shares of the company’s stock, valued at $164,045.70. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,254 shares of company stock valued at $1,411,969. 0.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

PRGO has been the topic of a number of research reports. StockNews.com raised shares of Perrigo from a “hold” rating to a “buy” rating in a research note on Monday, August 5th. Piper Sandler reduced their price objective on Perrigo from $36.00 to $35.00 and set an “overweight” rating on the stock in a research report on Thursday, July 11th.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.